These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1135207)

  • 1. [Combined treatment of experimental silicotuberculosis with poly-2-vinylpyridine-N-oxide and isoniazid].
    Frolova NN; Ozerova LV; Mordovskoĭ GG
    Probl Tuberk; 1975; (3):67-9. PubMed ID: 1135207
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic effectiveness of polyvinoxide in silicosis and silicotuberculosis].
    Zislin DM; Gol'del'man AG; Katsnel'son BA; Tikhotskaia LI; Rassokhina TG
    Gig Tr Prof Zabol; 1985 Nov; (11):21-5. PubMed ID: 4085887
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of polyvinylpyridine N-oxide for treating experimental silicosis and anthracosilicosis].
    Deĭnega VG; Bolonova LN; Sukhanov VV; Zemliakova LF; Tkachuk SV
    Gig Tr Prof Zabol; 1977; (6):25-8. PubMed ID: 892540
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of inhalations of polyvinylpyridine-N-oxide on the development of experimental silicosis].
    Rodkina BS; Bolonova LN
    Farmakol Toksikol; 1979; 42(1):81-4. PubMed ID: 421895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of polyvinylpyridine N-oxide on pulmonary tissue scleroproteins in experimental silicosis].
    Gel'fon IA
    Gig Tr Prof Zabol; 1978 Sep; (9):54. PubMed ID: 689462
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental silicosis caused by the dust from extra-pure crystalline silicon and the effect of polyvinylpyridine N-oxide on its course].
    Golodnikov IuN
    Gig Tr Prof Zabol; 1978 Dec; (12):31-6. PubMed ID: 720881
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cytopharmacologic effect of using polyvinylpyridine-N-oxide in experimental silicosis].
    Arutiunov VD; Kruglikov GG; Batsura IuD; Fedorova VI
    Biull Eksp Biol Med; 1977 Mar; 83(3):371-4. PubMed ID: 856357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly (2-vinylpyridine 1-oxide) in silicosis therapy: effective molecular weight.
    Hasirci VN; Holt PF
    Int Arch Occup Environ Health; 1977; 38(3):177-88. PubMed ID: 832913
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influence of polyvinylpyridine-N-oxide on matured experimental silicosis in the liver-spleen test].
    Heeren E; Eger W; Einbrodt HJ
    Beitr Silikoseforsch Pneumokoniose; 1971; 23(3):137-50. PubMed ID: 5171409
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antisilicotic activity of various amides of polymethacrylic acid].
    Aronova GV; Borodulina SN; Katsnel'son BA; Postovskiĭ IIa; Chasovskikh OM
    Gig Tr Prof Zabol; 1982 Feb; (2):15-7. PubMed ID: 7068001
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term follow-up observations of the therapeutic effect of PVNO on human silicosis.
    Zhao JD; Liu JD; Li GZ
    Zentralbl Bakteriol Mikrobiol Hyg B; 1983 Oct; 178(3):259-62. PubMed ID: 6659745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of a clinical trial of polyvinoxide in silicosis].
    Glotova KV; Senkevich NA; Kaliteevskaia TN; Pichugin VA; Manzhosova GB
    Gig Tr Prof Zabol; 1981 Aug; (8):14-7. PubMed ID: 7026373
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antisilicosis activity of PVPO administered intratracheally and by inhalation (an experimental study)].
    Rodkina BS; Bolonova LN
    Gig Tr Prof Zabol; 1979 Sep; (9):32-6. PubMed ID: 535751
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes induced by poly-2-vinylpyridine-N-oxide in susceptibility of macrophages to tubercular infection].
    Briatico-Vangosa G; Chiappino G
    Med Lav; 1973; 64(7):283-7. PubMed ID: 4208311
    [No Abstract]   [Full Text] [Related]  

  • 15. [Decomposition of collagen in experimental silicosis following treatment with polyvinylpyridine-N-oxide in dependence on the dosage].
    Pott F; Dehnen W; Brockhaus A
    Beitr Klin Erforsch Tuberk Lungenkr; 1970; 140(3):259-67. PubMed ID: 4314381
    [No Abstract]   [Full Text] [Related]  

  • 16. [CC1-4 detoxication by poly-2-vinylpyridine-N-oxide in rats].
    Antweiler H; Dehnen W
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):290-1. PubMed ID: 4253735
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatic protection in carbon tetrachloride experimental intoxication.
    Rotaru G; Constantinescu S; Filipescu G; Ratea E
    Morphol Embryol (Bucur); 1978; 24(2):149-56. PubMed ID: 149917
    [No Abstract]   [Full Text] [Related]  

  • 18. [Polyvinylpyridine N-oxide (Bay 3504, P-204, PVNO) in the treatment of human silicosis].
    Prügger F; Mallner B; Schlipköter HW
    Wien Klin Wochenschr; 1984 Dec; 96(23):848-53. PubMed ID: 6396971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Change in the phospholipid status in experimental silicosis in rats and in exposure to polymeric preparations].
    Kupina LM
    Gig Tr Prof Zabol; 1978 Sep; (9):16-20. PubMed ID: 689453
    [No Abstract]   [Full Text] [Related]  

  • 20. [Advances in the study of anti-silicotic agents].
    Huang FZ; Li QL; Qu SJ
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Apr; 9(2):118-21. PubMed ID: 3527609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.